Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immunohistochemical Expression of PD-L1 and IDH1 with Detection of MGMT Promoter Methylation in Astrocytoma.

Asian Pacific journal of cancer prevention : APJCP - 1 Dec 2022

Hareedy Amal Ahmed, Rohim El Zahraa Ahmed, Al Sheikh Samar Abdel Monem, Al Shereef Zeinab Abd El Azeem

Abstract excerpt

OBJECTIVE: Programmed death ligand 1 (PD-L1) expression was suggested as a poor prognostic predictor for glioblastoma. While isocitrate dehydrogenase (IDH) has been linked to enhanced overall survival in glioma cells. In glioblastoma patients receiving treatment with alkylating drugs, the methylguanine-DNA methyltransferase (MGMT) promoter's methylation status has been discovered as a potent and distinct...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Astrocytoma
Share to B7-H1 Antigen

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Brain Neoplasms

Share to DNA Modification Methylases

Share to DNA Repair Enzymes

Share to Glioblastoma

Share to Isocitrate Dehydrogenase

Share to Tumor Suppressor Proteins

Source

Open in PubMed Open full text

Identifiers

PMID: 36580017
DOI: 10.31557/APJCP.2022.23.12.4333
PMCID: PMC9971485

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immunohistochemical Expression of PD-L1 and IDH1 with Detection of MGMT Promoter Methylation in Astrocytoma.PMID 36580017Read ↗

Clinicopathological associations and prognostic values of IDH1 gene mutation, MGMT gene promoter methylation, and PD-L1 expressions in high-grade glioma treated with standard treatment.Semantic proximity Read ↗

Clinical Impact of IDH1 Mutations and MGMT Methylation in Adult GlioblastomaSemantic proximity Read ↗

Mismatch repair proteins PMS2 and MLH1 can further refine molecular stratification of IDH-mutant lower grade astrocytomas.Semantic proximity Read ↗

MGMT promoter hypermethylation and its associations with genetic alterations in a series of 350 brain tumors.Semantic proximity Read ↗

[IDH1 mutation and MGMT expression in astrocytoma and the relationship with prognosis after radiotherapy].Semantic proximity Read ↗

Clinical Impact of <i>IDH1</i> Mutations and <i>MGMT</i> Methylation in Adult Glioblastoma MultiformeSemantic proximity Read ↗

An Analysis of the Prognostic Value of IDH1 (Isocitrate Dehydrogenase 1) Mutation in Polish Glioma PatientsSemantic proximity Read ↗

Expression of CD133 Cancer Stem Cell Marker in IDH-Mutant and IDH-wildtype (Isocitrate Dehydrogenase) Astrocytoma.Semantic proximity Read ↗

IDH1 mutations in grade II astrocytomas are associated with unfavorable progression-free survival and prolonged postrecurrence survival.Semantic proximity Read ↗

Integrated analysis of programmed cell death ligand 1 expression reveals increased levels in high-grade gliomaSemantic proximity Read ↗

Methylation profiles of thirty four promoter-CpG islands and concordant methylation behaviours of sixteen genes that may contribute to carcinogenesis of astrocytomaSemantic proximity Read ↗

IDH1 and IDH2 mutations, immunohistochemistry and associations in a series of brain tumors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.